Adrian Adams

Adrian Adams, listed as chief executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Akebia Therapeutics, Inc., Talphera, Inc. and Aralez Pharmaceuticals Inc. We count 14 filings; the first trade dates from 5 February 2016 and the latest from 22 June 2026.

Purchases make up the whole of the open-market record (1 purchase, €203k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 12 share grants.

The newest entry dates from 24 June 2026: a share grant, in Talphera, Inc. The last purchase on record was published on 19 August 2021, which is 1,886 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.